Donald R. Fleming

984 total citations
25 papers, 740 citations indexed

About

Donald R. Fleming is a scholar working on Oncology, Hematology and Surgery. According to data from OpenAlex, Donald R. Fleming has authored 25 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Hematology and 6 papers in Surgery. Recurrent topics in Donald R. Fleming's work include Neutropenia and Cancer Infections (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Donald R. Fleming is often cited by papers focused on Neutropenia and Cancer Infections (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Donald R. Fleming collaborates with scholars based in United States, Germany and Greece. Donald R. Fleming's co-authors include Stephen P. Slone, Vivek R. Sharma, Juanita Garrison, Daniel J. Booser, Gabriel N. Hortobágyi, Bayard L. Powell, Ronald B. Gartenhaus, Edgardo Rivera, Franklin C. Wong and Fraser Symmans and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Donald R. Fleming

25 papers receiving 718 citations

Peers

Countries citing papers authored by Donald R. Fleming

Since Specialization

Citations

This map shows the geographic impact of Donald R. Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald R. Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald R. Fleming more than expected).

Fields of papers citing papers by Donald R. Fleming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald R. Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald R. Fleming. The network helps show where Donald R. Fleming may publish in the future.

Co-authorship network of co-authors of Donald R. Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of Donald R. Fleming. A scholar is included among the top collaborators of Donald R. Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald R. Fleming. Donald R. Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma 2005 ·Cancer ·Lajos Pusztai, Peter J. Wagner, Nuhad K. Ibrahim, Edgardo Rivera, Richard L. Theriault, Daniel J. Booser, Fraser Symmans, Franklin C. Wong, George Blumenschein, Donald R. Fleming, Roman Rouzier, G. R. Boniface, Gabriel N. Hortobágyi	238
2	Sinus Histiocytosis With Massive Lymphadenopathy and Langerhans Cell Histiocytosis Express the Cellular Adhesion Molecule CD31 2003 ·Archives of Pathology & Laboratory Medicine ·Stephen P. Slone, Donald R. Fleming, John J. Buchino	22
3	DAB₃₈₉IL2 (ONTAK^®) fusion protein therapy of chronic lymphocytic leukaemia 2003 ·Expert Opinion on Biological Therapy ·Arthur E. Frankel, Donald R. Fleming, Bayard L. Powell, Ronald B. Gartenhaus	37
4	Cefepime Versus Ticarcillin and Clavulanate Potassium and Aztreonam for Febrile Neutropenia Therapy in High-Dose Chemotherapy Patients 2003 ·American Journal of Clinical Oncology ·Donald R. Fleming, Craig Ziegler, (unknown), (unknown), George H. Goldsmith, Roger H. Herzig	7
5	A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia. 2003 ·PubMed ·Arthur E. Frankel, Donald R. Fleming, Philip D. Hall, Bayard L. Powell, J Black, (unknown), Ronald B. Gartenhaus	60
6	Challenges in Oncology 2002 ·Journal of Clinical Oncology ·(unknown), Donald R. Fleming, (unknown)	24
7	Solitary Plasmacytoma in the Setting of Langerhans Cell Histiocytosis 2002 ·Hematology ·Vivek R. Sharma, Donald R. Fleming, Lung T. Yam	2
8	Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer 2001 ·British Journal of Cancer ·P. Vasey, R. Atkinson, Robert E. Coleman, Michael Crawford, Margaret Cruickshank, (unknown), Donald R. Fleming, John D. Graham, David E. Parkin, James Paul, N.S. Reed, Stan B. Kaye	64
9	Mobilization of Peripheral Blood Stem Cells in High-Risk Breast Cancer Patients Using G-CSF After Standard Dose Docetaxel 2000 ·Journal of Hematotherapy & Stem Cell Research ·Donald R. Fleming, (unknown), George H. Goldsmith, Don A. Stevens, Roger H. Herzig	6
10	Diagnostic and Clinical Implications of Lineage Fidelity in Acute Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation 2000 ·Leukemia & lymphoma ·Donald R. Fleming, Michael Doukas, (unknown), Diane D. Davey	2
11	Phase I Study of Paclitaxel and Day 1/Day 8 Gemcitabine in Patients With Solid Malignancies 2000 ·American Journal of Clinical Oncology ·Donald R. Fleming, (unknown), (unknown), (unknown), George H. Goldsmith, Renato V. LaRocca	15
12	Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab 2000 ·Blood ·Vivek R. Sharma, Donald R. Fleming, Stephen P. Slone	38
13	Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab 2000 ·Blood ·Vivek R. Sharma, Donald R. Fleming, Stephen P. Slone	85
14	The transfusion needs of an autologous bonemarrow transplant patient with IgA deficiency 1999 ·Transfusion ·(unknown), Donald R. Fleming, (unknown), R H Herzig	2
15	Dose-Intensive Chemotherapy for Breast Cancer With Brain Metastases 1999 ·American Journal of Clinical Oncology ·Donald R. Fleming, (unknown), Don A. Stevens, Roger H. Herzig	2
16	Identical twin marrow transplantation for venous thrombosis in paroxysmal nocturnal hemoglobinuria; long-term complete remission as assessed by flow cytometry 1998 ·Bone Marrow Transplantation ·(unknown), Donald R. Fleming, (unknown)	12
17	Impact of obesity on allogeneic stem cell transplant patients: A matched case-controlled study 1997 ·The American Journal of Medicine ·Donald R. Fleming, Mary Kay Rayens, Juanita Garrison	51
18	Lymphocyte Infusion for Delayed Extramedullary Relapse of Acute Leukemia Following Bone Marrow Transplantation 1996 ·Leukemia & lymphoma ·Donald R. Fleming, Martha F. Greenwood, Juanita Garrison, John D. Geil, Edward H. Romond	15
19	Acute Tumor Lysis Syndrome in Hematologic Malignancies 1992 ·Leukemia & lymphoma ·Donald R. Fleming, Michail Doukas	29
20	Intraoral squamous cell carcinoma in South Africa. 1982 ·PubMed ·Donald R. Fleming, M. Shear, Mattia Altini	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact